Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Novus Biologicals LLC Stories

2013-10-30 23:03:37

Acquisition further strengthens Novus’ catalog of more than 200,000 Life Sciences products Littleton, Colo. (PRWEB) October 30, 2013 Novus Biologicals, a leading developer and marketer of Life Sciences products, is pleased to announce its acquisition of San Diego-based Imgenex Corporation. Imgenex is a provider of specialized reagents for Life Science research with particular strength in the areas of Innate and Adaptive Immunity, Apoptosis and Cancer. The acquisition of Imgenex...

2013-01-24 12:27:05

LITTLETON, Colo., Jan. 24, 2013 /PRNewswire/ -- Novus Biologicals LLC, a leading provider of antibodies and reagents to the life science research community, has hired David Eansor to lead a new corporate-development effort. Eansor, a 13-year veteran in the life science market who was most recently the president of Thermo Fisher Scientific's bioscience division, joined Novus in January as senior vice-president of corporate development. In this new role, Eansor is tasked with accelerating...